News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Christine Daragjati, BS

Articles by Christine Daragjati, BS

Clinical Outcome of a Mandatory Formulary Switch for Dihydropyridine Calcium Channel Blocker Therapy at a Veteran's Administration Medical Center

ByGabriel Gustin, MD,William B. White, MD,Stacy Taylor, BA,Christine Daragjati, BS

December 1st 1996

Latest Updated Articles

Clinical Outcome of a Mandatory Formulary Switch for Dihydropyridine Calcium Channel Blocker Therapy at a Veteran's Administration Medical Center
Published: December 1st 1996 | Updated:

Trending on AJMC

Team-Based Precision Oncology: Advancing Value and Access in Cancer Care

Navigating Costs and Logistics of Cellular Therapies, ADCs, and Novel Diagnostics in Cancer Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.